News
-
-
PRESS RELEASE
Bouygues: Nine-month 2025 results
-
-
-
REGULATED PRESS RELEASE
Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only sequencing-based solution to rapidly characterize drug resistant-tuberculosis
Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only solution for rapid characterization of drug resistant-tuberculosis, using nanopore sequencing technology -
-
-
-
PRESS RELEASE
Klöckner & Co doubles operating income before material special effects in third quarter of 2025 and continues positive trend
Klöckner & Co SE doubles operating income before special effects, reports €43 million EBITDA in Q3 2025. Sales slightly down but positive trend continues. Focus on higher value-added business and service centers -